Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
06/2012
06/05/2012CA2582984C Novel use of .alpha.-sympathomimetics having a 2-imidazoline structure
06/05/2012CA2557275C Bicyclo derivative
06/05/2012CA2539349C 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
06/05/2012CA2489041C Bafilomycin-like metabolite from a novel micromonospora species
06/05/2012CA2482041C 4-chromanone derivatives for treating cellular proliferative diseases and disorders
06/05/2012CA2435419C Halogenated composition, method for preparing same and uses thereof
06/05/2012CA2406278C Inhibitors of human phosphatidyl-inositol 3-kinase delta
06/05/2012CA2403701C Recombinant parainfluenza virus expression systems and vaccines
06/05/2012CA2397359C Composition of antigen and glycolipid adjuvant sublingual administration
06/05/2012CA2368670C Modulation of vascular permeability by means of tie2 receptor activators
06/05/2012CA2324226C Inhibitors of caspases
06/05/2012CA2292882C Mutant having uracil phosphoribosyl transferase activity
06/05/2012CA2248667C Hla-a2.1 binding peptides and their uses
05/2012
05/31/2012WO2012071521A2 Adjuvant
05/31/2012WO2012071324A2 Pharmaceutical compositions
05/31/2012WO2012070975A1 Modified peptides with antiviral properties and method for the production thereof
05/31/2012WO2012070974A1 Vaccines with enhanced immunogenicity and methods for the production thereof
05/31/2012WO2012070967A1 Wound-healing, burn-treating, regenerative and antiviral pharmaceutical composition for topical application
05/31/2012WO2012070798A2 Topical antifungal composition comprising terbinafine or its salt
05/31/2012WO2012070071A1 Compounds and their use
05/31/2012WO2012070027A1 A drug delivery device
05/31/2012WO2012069743A1 Nitrobenzothiazole derivatives and use thereof for treating tuberculosis
05/31/2012WO2012069432A1 Use of kinesin inhibitors in hiv infection treatment and a method for screening them
05/31/2012WO2012069380A1 Antifungal 5,6-dihydro-4h-pyrrolo[1,2-a][1,4]-benzodiazepines and 6h-pyrrolo[1,2-a][1,4]benzodiazepines substituted with phenyl derivatives
05/31/2012WO2012068870A1 Ternary complex, liquid containing ternary complex, preparing method and use thereof
05/31/2012WO2012068637A1 Compositions and methods
05/31/2012WO2012068622A1 Compounds for treating respiratory syncytial virus infections
05/31/2012WO2012047870A3 Antimicrobial preservation of propofol emulsions
05/31/2012WO2012040224A3 Oral composition and method of forming and using same
05/31/2012WO2012037485A9 Methods of inhibiting alphavirus replication and treating alphavirus infection
05/31/2012WO2012034025A3 Human cytomegalovirus vaccine
05/31/2012WO2012030626A3 Design of oligonucleotide analogs as therapeutic agents
05/31/2012WO2012030535A3 Bacteriophage lytic enzymes as alternative antimicrobials
05/31/2012WO2012027411A9 Compositions and uses of materials with high antimicrobial activity and low toxicity
05/31/2012WO2012026878A8 Monoclonal antibody specific to major neutralizing epitope of influenza h5 hemagglutinin
05/31/2012WO2012024363A3 Compounds and methods for the treatment or prevention of flaviviridae viral infections
05/31/2012WO2012021735A8 Pharmaceutical products from fungal strains
05/31/2012WO2012015242A3 Novel antimicrobial composition, and method for preparing same
05/31/2012WO2011160043A3 Pla2g16 as a target for antiviral compounds
05/31/2012WO2011146933A3 Universal dengue virus sequences and methods of use
05/31/2012WO2011146891A3 High-affinity fully functional soluble single-domain human cd4, antibodies, and related fusion proteins
05/31/2012WO2011143653A3 Recombinant hcmv and rhcmv vectors and uses thereof
05/31/2012US20120136338 Immunologic compounds for prevention, protection, prophylaxis or treatment of immunological disorders, infections and cancer
05/31/2012US20120136323 Wound Dressings, Methods of Using the Same and Methods of Forming the Same
05/31/2012US20120136142 Vaccine Compositions For Marburg Virus
05/31/2012US20120136071 Medicinal Cream For Diaper Rash And A Process To Make It
05/31/2012US20120136069 Alcoholic Pump Foam
05/31/2012US20120136049 Antibacterial agent
05/31/2012US20120136040 Hybrid interfering rna
05/31/2012US20120136031 P38map kinase inhibitor
05/31/2012US20120136027 Phenyl Ethynyl Derivatives As Hepatitis C Virus Inhibitors
05/31/2012US20120136026 5-membered heterocyclic compound cyclopenta[c]pyrrolylalkylcarbamate derivatives, preparation thereof, and therapeutic use thereof
05/31/2012US20120136023 Inhibitors of HIV Replication
05/31/2012US20120136017 Use of 4'-thio-2'-deoxynucleosides as anti orthopoxvirus agents
05/31/2012US20120136014 Dihydrofolate reductase inhibitors
05/31/2012US20120135999 Compounds and methods for antiviral treatment
05/31/2012US20120135998 Compounds for treating respiratory syncytial virus infections
05/31/2012US20120135994 Inhibitors of human phosphatidylinositol 3-kinase delta
05/31/2012US20120135972 Phthalocyanine derivative consisting of a mixture of 4 isomers
05/31/2012US20120135968 Tetracycline Compounds
05/31/2012US20120135965 Amorphous fosamprenavir calcium
05/31/2012US20120135961 Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections
05/31/2012US20120135959 Metalloprotein inhibitors containing nitrogen based ligands
05/31/2012US20120135958 Tetrahydroquinoxaline urea derivatives, preparation thereof, and therapeutic use thereof
05/31/2012US20120135954 Compounds for preventing or treating viral infections and methods of use thereof
05/31/2012US20120135953 Bis-Benzimidazole Derivatives As Hepatitis C Virus Inhibitors
05/31/2012US20120135951 3'-azido purine nucleotide prodrugs for treatment of viral infections
05/31/2012US20120135950 Antiviral treatment of lymphoma and cancer
05/31/2012US20120135949 Combination therapy for treating hcv infection
05/31/2012US20120135948 Antibacterial aminoglycoside analogs
05/31/2012US20120135946 Antibacterial aminoglycoside analogs
05/31/2012US20120135945 Antibacterial aminoglycoside analogs
05/31/2012US20120135942 Beta-hairpin peptidomimetics
05/31/2012US20120135925 Covalent Inhibition of Bacterial Quorum Sensing
05/31/2012US20120135916 Monomeric and dimeric forms of adiponectin receptor fragments and methods of use
05/31/2012US20120135501 Recombinant poxvirus expressing homologous genes inserted
05/31/2012US20120135093 Soap composition for treating acne containing absolute ginseng essential oil
05/31/2012US20120135092 INHIBITORS OF RecA ACTIVITIES FOR CONTROL OF ANTIBIOTIC-RESISTANT BACTERIAL PATHOGENS
05/31/2012US20120135085 Method and composition for disinfection and purification
05/31/2012US20120135084 Use of Deuterium Oxide for Treating Viral Diseases of the Eye
05/31/2012US20120135070 Copolymers
05/31/2012US20120135068 Liposome-encapsulated glutathione for oral administration
05/31/2012US20120135067 Vaccine for mycoplasma infection
05/31/2012US20120135045 Antimicrobial Collagenous Constructs
05/31/2012US20120135040 Temperature sensitive vaccine strain of mycoplasma hyopneumoniae and uses thereof
05/31/2012US20120135039 Oral Vaccines for Producing Mucosal Immunity
05/31/2012US20120135037 Flagellin fusion proteins and conjugates comprising pneumococcus antigens and methods of using the same
05/31/2012US20120135034 Non-Integrating Retroviral Vector Vaccines
05/31/2012US20120135032 Generation of a broad t-cell response in humans against hiv
05/31/2012US20120135031 Method of enhancing an immune response
05/31/2012US20120135030 Method of Producing Protein-Carbohydrate Vaccines Reduced in Free Carbohydrate
05/31/2012US20120135028 Vaccine
05/31/2012US20120135026 Combination neisserial compositions
05/31/2012US20120135025 Chlamydia antigens and uses thereof
05/31/2012US20120135024 Neisseria meningitidis antigens and compositions
05/31/2012US20120135023 Influenza hemagglutinin and neuraminidase variants
05/31/2012US20120135017 Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
05/31/2012US20120135013 CD45 and Methods and Compounds Related Thereto
05/31/2012US20120135011 Method for in vivo expansion of T regulatory cells
05/31/2012US20120135009 Cleaved and Phosphorylated CRMP2 as Blood Marker of Inflammatory Diseases of the Central Nervous System
1 ... 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 ... 1798